Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 400363)

Published in J Virol on May 01, 2004

Authors

Karine Triques1, Mario Stevenson

Author Affiliations

1: Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA.

Articles citing this

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol (2012) 5.71

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One (2008) 3.85

Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol (2006) 3.80

A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe (2009) 2.34

Macrophages archive HIV-1 virions for dissemination in trans. EMBO J (2005) 2.27

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology (2009) 2.02

Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood (2007) 1.93

APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog (2011) 1.90

Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol (2008) 1.41

Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology (2010) 1.33

p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway. Proc Natl Acad Sci U S A (2013) 1.31

Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol (2012) 1.22

Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol (2009) 1.22

Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell Immunol (2010) 1.21

Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. J Virol (2009) 1.20

Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology (2009) 1.17

Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture. Antimicrob Agents Chemother (2009) 1.15

HIV-1 pathogenesis: the virus. Cold Spring Harb Perspect Med (2012) 1.03

Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS One (2008) 1.01

Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS. PLoS One (2011) 0.99

Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors. J Virol (2011) 0.99

IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation. J Exp Med (2013) 0.98

Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj. PLoS One (2009) 0.96

Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply. Retrovirology (2013) 0.94

HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis. APMIS (2009) 0.94

HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med (2006) 0.93

HIV-1 transforms the monocyte plasma membrane proteome. Cell Immunol (2009) 0.93

MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses (2012) 0.90

New insights into an X-traordinary viral protein. Front Microbiol (2014) 0.90

Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. J Biol Chem (2012) 0.89

R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes. BMC Infect Dis (2012) 0.86

Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. J Virol (2005) 0.85

miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. PLoS One (2014) 0.85

HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies. J Leukoc Biol (2013) 0.85

Restricted HIV-1 replication in placental macrophages is caused by inefficient viral transcription. J Leukoc Biol (2009) 0.83

Chemical transfection of dye-conjugated microRNA precursors for microRNA functional analysis of M2 macrophages. J Cell Biochem (2012) 0.80

Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells. Virol J (2011) 0.80

Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy. PLoS One (2013) 0.79

β-Catenin/TCF-4 signaling regulates susceptibility of macrophages and resistance of monocytes to HIV-1 productive infection. Curr HIV Res (2014) 0.79

Restricted 5'-end gap repair of HIV-1 integration due to limited cellular dNTP concentrations in human primary macrophages. J Biol Chem (2013) 0.78

The susceptibility of primate lentiviruses to nucleosides and Vpx during infection of dendritic cells is regulated by CA. J Virol (2015) 0.77

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation. Immunol Cell Biol (2016) 0.75

Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing. J Virol (2016) 0.75

Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection. J Leukoc Biol (2017) 0.75

Articles cited by this

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60

The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15

HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J (1990) 9.34

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol (2000) 8.62

Identification of the haemoglobin scavenger receptor. Nature (2001) 7.05

Modulation of HIV-1 replication by RNA interference. Nature (2002) 5.90

A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol (2002) 5.49

A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci U S A (2002) 4.52

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med (1989) 3.22

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol (2002) 2.89

Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol (2002) 2.59

Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A (1989) 2.50

Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal Biochem (1989) 2.41

Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest (1992) 2.28

Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell (1998) 2.23

Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine (2000) 2.18

Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J Virol (1999) 1.97

Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol (1991) 1.92

CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85

The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem (2002) 1.69

Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.63

Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses (1998) 1.62

Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol (2001) 1.60

Origin and turnover of monocytes and macrophages. Curr Top Pathol (1989) 1.54

Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology (2001) 1.23

HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS (1998) 1.21

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther (2000) 1.20

Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Infect Dis (1999) 0.95

Current views on the ontogeny of macrophages and the humoral regulation of monocytopoiesis. Trans R Soc Trop Med Hyg (1983) 0.89

Articles by these authors

Modulation of HIV-1 replication by RNA interference. Nature (2002) 5.90

Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med (2010) 5.36

Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science (2004) 5.31

Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A (2014) 2.95

HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature (2003) 2.90

Small-molecule inhibition of HIV-1 Vif. Nat Biotechnol (2008) 2.83

Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog (2008) 2.72

A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe (2009) 2.34

Macrophages archive HIV-1 virions for dissemination in trans. EMBO J (2005) 2.27

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature (2006) 2.02

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. J Virol (2005) 1.80

Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog (2007) 1.61

Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. Antivir Ther (2011) 1.41

Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. PLoS Pathog (2011) 1.32

Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe (2008) 1.31

Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A (2002) 1.27

Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol (2004) 1.26

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med (2002) 1.23

Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog (2011) 1.21

Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. J Leukoc Biol (2006) 1.19

In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio (2013) 1.18

Overcoming pharmacologic sanctuaries. Curr Opin HIV AIDS (2013) 1.17

Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol (2006) 1.14

HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol (2003) 1.13

Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J Virol (2005) 1.06

Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology (2004) 1.05

The search for a cure for persistent HIV reservoirs. AIDS Rev (2011) 0.98

The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages. J Virol (2012) 0.97

Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication. Chembiochem (2009) 0.95

HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro. AIDS Res Hum Retroviruses (2012) 0.89

HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children. J Immunol (2003) 0.89

A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J Virol (2011) 0.89

Synthesis and structure-activity relationship studies of HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication. ChemMedChem (2012) 0.87

Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification. J Acquir Immune Defic Syndr (2013) 0.86

Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus. J Virol (2010) 0.81

A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol (2010) 0.80

Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir. AIDS Res Hum Retroviruses (2015) 0.77

TRIMming HIV-1's mainsail. Nat Immunol (2004) 0.76

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure. AIDS Res Ther (2012) 0.75

Tat's seductive side. Nat Med (2003) 0.75

Unsung hero Robert C. Gallo. Science (2009) 0.75

A plea for justice for jailed medical workers. Science (2006) 0.75

Zika Virus: Obstetric and Pediatric Anesthesia Considerations. Anesth Analg (2017) 0.75